STRYKER CORP Cost of Revenue
STRYKER CORP (SYK) reported Cost of Revenue of $2.09 billion for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-31.
Financial Statements › Expense Statement
us-gaap:CostOfRevenue · last filed 2026-07-31
- STRYKER CORP cost of revenue for the quarter ending 2026-06-30 was $2.09B, a 4.13% decline year-over-year.
- STRYKER CORP cost of revenue for the quarter ending 2026-03-31 was $2.21B, a 4.15% increase year-over-year.
- STRYKER CORP cost of revenue for the quarter ending 2025-12-31 was $2.54B, a 12.42% increase year-over-year.
- STRYKER CORP cost of revenue for the quarter ending 2025-09-30 was $2.21B, a 11.53% increase year-over-year.
- STRYKER CORP cost of revenue for fiscal 2025 was $9.05B, a 10.99% increase from fiscal 2024.
- STRYKER CORP cost of revenue for fiscal 2024 was $8.15B, a 9.61% increase from fiscal 2023.
- STRYKER CORP cost of revenue for fiscal 2023 was $7.44B, a 8.28% increase from fiscal 2022.
- STRYKER CORP cost of revenue for fiscal 2022 was $6.87B, a 11.91% increase from fiscal 2021.
| Period end | Cost of Revenue 3 month | Cost of Revenue 6 month | Cost of Revenue 9 month | Cost of Revenue 12 month |
|---|---|---|---|---|
| 2026-06-30 | $2.09B 10-Q · filed 2026-07-31 | $4.30B 10-Q · filed 2026-07-31 | $6.84B derived: sum of 3 quarters · filed 2026-07-31 | $9.05B derived: sum of 4 quarters · filed 2026-07-31 |
| 2026-03-31 | $2.21B 10-Q · filed 2026-05-11 | $4.75B derived: sum of 2 quarters · filed 2026-05-11 | $6.96B derived: sum of 3 quarters · filed 2026-05-11 | $9.14B derived: sum of 4 quarters · filed 2026-07-31 |
| 2025-12-31 | $2.54B derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-11 | $4.75B derived: sum of 2 quarters · filed 2026-02-11 | $6.93B derived: sum of 3 quarters · filed 2026-07-31 | $9.05B 10-K · filed 2026-02-11 |
| 2025-09-30 | $2.21B 10-Q · filed 2025-10-31 | $4.39B derived: sum of 2 quarters · filed 2026-07-31 | $6.51B 10-Q · filed 2025-10-31 | $8.77B derived: sum of 4 quarters · filed 2026-07-31 |
| 2025-06-30 | $2.18B 10-Q · filed 2026-07-31 | $4.30B 10-Q · filed 2026-07-31 | $6.57B derived: sum of 3 quarters · filed 2026-07-31 | $8.54B derived: sum of 4 quarters · filed 2026-07-31 |
| 2025-03-31 | $2.12B 10-Q · filed 2026-05-11 | $4.38B derived: sum of 2 quarters · filed 2026-05-11 | $6.36B derived: sum of 3 quarters · filed 2026-05-11 | $8.37B derived: sum of 4 quarters · filed 2026-05-11 |
| 2024-12-31 | $2.26B derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-11 | $4.24B derived: sum of 2 quarters · filed 2026-02-11 | $6.25B derived: sum of 3 quarters · filed 2026-02-11 | $8.15B 10-K · filed 2026-02-11 |
| 2024-09-30 | $1.98B 10-Q · filed 2025-10-31 | $3.98B derived: sum of 2 quarters · filed 2025-10-31 | $5.89B 10-Q · filed 2025-10-31 | $8.01B derived: sum of 4 quarters · filed 2026-02-11 |
| 2024-06-30 | $2.01B 10-Q · filed 2025-08-01 | $3.92B 10-Q · filed 2025-08-01 | $6.03B derived: sum of 3 quarters · filed 2026-02-11 | $7.78B derived: sum of 4 quarters · filed 2026-02-11 |
| 2024-03-31 | $1.91B 10-Q · filed 2025-05-02 | $4.02B derived: sum of 2 quarters · filed 2026-02-11 | $5.77B derived: sum of 3 quarters · filed 2026-02-11 | $7.59B derived: sum of 4 quarters · filed 2026-02-11 |
| 2023-12-31 | $2.11B derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-11 | $3.86B derived: sum of 2 quarters · filed 2026-02-11 | $5.68B derived: sum of 3 quarters · filed 2026-02-11 | $7.44B 10-K · filed 2026-02-11 |
| 2023-09-30 | $1.75B 10-Q · filed 2024-10-30 | $3.57B derived: sum of 2 quarters · filed 2024-10-30 | $5.33B 10-Q · filed 2024-10-30 | $7.29B derived: sum of 4 quarters · filed 2025-02-12 |
| 2023-06-30 | $1.81B 10-Q · filed 2024-07-31 | $3.58B 10-Q · filed 2024-07-31 | $5.54B derived: sum of 3 quarters · filed 2025-02-12 | $7.24B derived: sum of 4 quarters · filed 2025-02-12 |
| 2023-03-31 | $1.76B 10-Q · filed 2024-05-01 | $3.73B derived: sum of 2 quarters · filed 2025-02-12 | $5.42B derived: sum of 3 quarters · filed 2025-02-12 | $7.09B derived: sum of 4 quarters · filed 2025-02-12 |
| 2022-12-31 | $1.97B derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-12 | $3.66B derived: sum of 2 quarters · filed 2025-02-12 | $5.33B derived: sum of 3 quarters · filed 2025-02-12 | $6.87B 10-K · filed 2025-02-12 |
| 2022-09-30 | $1.70B 10-Q · filed 2023-11-03 | $3.36B derived: sum of 2 quarters · filed 2023-11-03 | $4.91B 10-Q · filed 2023-11-03 | $6.56B derived: sum of 4 quarters · filed 2024-02-14 |
| 2022-06-30 | $1.67B 10-Q · filed 2023-08-04 | $3.21B 10-Q · filed 2023-08-04 | $4.86B derived: sum of 3 quarters · filed 2024-02-14 | $6.38B derived: sum of 4 quarters · filed 2024-02-14 |
| 2022-03-31 | $1.54B 10-Q · filed 2023-05-02 | $3.20B derived: sum of 2 quarters · filed 2024-02-14 | $4.71B derived: sum of 3 quarters · filed 2024-02-14 | $6.24B derived: sum of 4 quarters · filed 2024-02-14 |
| 2021-12-31 | $1.66B derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-14 | $3.17B derived: sum of 2 quarters · filed 2024-02-14 | $4.70B derived: sum of 3 quarters · filed 2024-02-14 | $6.14B 10-K · filed 2024-02-14 |
| 2021-09-30 | $1.52B 10-Q · filed 2022-11-01 | $3.04B derived: sum of 2 quarters · filed 2022-11-01 | $4.48B 10-Q · filed 2022-11-01 | $6.03B derived: sum of 4 quarters · filed 2023-02-10 |
| 2021-06-30 | $1.52B 10-Q · filed 2022-07-27 | $2.97B 10-Q · filed 2022-07-27 | $4.51B derived: sum of 3 quarters · filed 2023-02-10 | $5.79B derived: sum of 4 quarters · filed 2023-02-10 |
| 2021-03-31 | $1.44B 10-Q · filed 2022-04-29 | $2.99B derived: sum of 2 quarters · filed 2023-02-10 | $4.26B derived: sum of 3 quarters · filed 2023-02-10 | $5.48B derived: sum of 4 quarters · filed 2023-02-10 |
| 2020-12-31 | $1.54B derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-10 | $2.82B derived: sum of 2 quarters · filed 2023-02-10 | $4.04B derived: sum of 3 quarters · filed 2023-02-10 | $5.29B 10-K · filed 2023-02-10 |
| 2020-09-30 | $1.28B 10-Q · filed 2021-10-29 | $2.49B derived: sum of 2 quarters · filed 2021-10-29 | $3.75B 10-Q · filed 2021-10-29 | $5.18B derived: sum of 4 quarters · filed 2022-02-11 |
| 2020-06-30 | $1.22B 10-Q · filed 2021-07-28 | $2.47B 10-Q · filed 2021-07-28 | $3.90B derived: sum of 3 quarters · filed 2022-02-11 | $5.16B derived: sum of 4 quarters · filed 2022-02-11 |
| 2020-03-31 | $1.26B 10-Q · filed 2021-04-28 | $2.69B derived: sum of 2 quarters · filed 2022-02-11 | $3.94B derived: sum of 3 quarters · filed 2022-02-11 | $5.21B derived: sum of 4 quarters · filed 2022-02-11 |
| 2019-12-31 | $1.43B derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-11 | $2.69B derived: sum of 2 quarters · filed 2022-02-11 | $3.96B derived: sum of 3 quarters · filed 2022-02-11 | $5.19B 10-K · filed 2022-02-11 |
| 2019-09-30 | $1.26B 10-Q · filed 2020-10-30 | $2.53B derived: sum of 2 quarters · filed 2020-10-30 | $3.76B 10-Q · filed 2020-10-30 | $5.10B derived: sum of 4 quarters · filed 2021-02-11 |
| 2019-06-30 | $1.27B 10-Q · filed 2020-07-31 | $2.50B 10-Q · filed 2020-07-31 | $3.84B derived: sum of 3 quarters · filed 2021-02-11 | $4.93B derived: sum of 4 quarters · filed 2021-02-11 |
| 2019-03-31 | $1.23B 10-Q · filed 2020-05-01 | $2.57B derived: sum of 2 quarters · filed 2021-02-11 | $3.66B derived: sum of 3 quarters · filed 2021-02-11 | $4.79B derived: sum of 4 quarters · filed 2021-02-11 |
| 2018-12-31 | $1.34B derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-11 | $2.43B derived: sum of 2 quarters · filed 2021-02-11 | $3.56B derived: sum of 3 quarters · filed 2021-02-11 | $4.66B 10-K · filed 2021-02-11 |
| 2018-09-30 | $1.09B 10-Q · filed 2019-10-30 | $2.22B derived: sum of 2 quarters · filed 2019-10-30 | $3.32B 10-Q · filed 2019-10-30 | $4.55B derived: sum of 4 quarters · filed 2020-02-06 |
| 2018-06-30 | $1.13B 10-Q · filed 2019-07-26 | $2.24B 10-Q · filed 2019-07-26 | $3.47B derived: sum of 3 quarters · filed 2020-02-06 | $4.49B derived: sum of 4 quarters · filed 2020-02-06 |
| 2018-03-31 | $1.10B 10-Q · filed 2019-04-24 | $2.33B derived: sum of 2 quarters · filed 2020-02-06 | $3.36B derived: sum of 3 quarters · filed 2020-02-06 | |
| 2017-12-31 | $1.23B derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-06 | $2.25B derived: sum of 2 quarters · filed 2020-02-06 | $4.26B 10-K · filed 2020-02-06 | |
| 2017-09-30 | $1.02B 10-Q · filed 2018-10-26 | $3.03B 10-Q · filed 2018-10-26 | ||
| 2016-12-31 | $3.82B 10-K · filed 2019-02-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| 3M CO (MMM) | United States | $86.404B | 27.87 |
| BOSTON SCIENTIFIC CORP (BSX) | United States | $64.781B | 17.29 |
| BECTON DICKINSON & CO (BDX) | United States | $48.834B | 43.79 |
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |